Search for Patents Expiring in 2023

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Product	Substance	Delist Req.	Patent Expiration	Patented / Exclusive Use
Sanofi Aventis Us	APIDRA	insulin glulisine recombinant	021629	Dec 20, 2005	RX	Yes	6,960,561	Y			Jan 25, 2023	METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
Sanofi Aventis Us	APIDRA	insulin glulisine recombinant	021629	Apr 16, 2004	RX	Yes	6,960,561	Y			Jan 25, 2023	METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
Sanofi Aventis Us	APIDRA SOLOSTAR	insulin glulisine recombinant	021629	Feb 24, 2009	RX	No	6,960,561	Y			Jan 25, 2023	METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS

20 30 40 50 100

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.